<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Contemp Clin Dent</journal-id><journal-id journal-id-type="iso-abbrev">Contemp Clin Dent</journal-id><journal-id journal-id-type="publisher-id">CCD</journal-id><journal-title-group><journal-title>Contemporary Clinical Dentistry</journal-title></journal-title-group><issn pub-type="ppub">0976-237X</issn><issn pub-type="epub">0976-2361</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23853452</article-id><article-id pub-id-type="pmc">3703694</article-id><article-id pub-id-type="publisher-id">CCD-4-48</article-id><article-id pub-id-type="doi">10.4103/0976-237X.111615</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparative evaluation of locally delivered minocycline and metronidazole in the treatment of periodontitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pandit</surname><given-names>Nymphea</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Dahiya</surname><given-names>Ritu</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Rajan</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib><contrib contrib-type="author"><name><surname>Bali</surname><given-names>Deepika</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Kathuria</surname><given-names>Abhinav</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib></contrib-group><aff id="aff1"><italic>Department of Periodontology and Implantology, D.A.V. (c) Dental College, Model Town, Yamuna Nagar, Haryana, India</italic></aff><aff id="aff2"><label>1</label><italic>Department of Periodontology and Implantology, P.D.M. Dental College, Bahadurgarh, Haryana, India</italic></aff><aff id="aff3"><label>2</label><italic>Himachal Institute of Dental Sciences, Ponta Sahib, Himachal Pradesh, India</italic></aff><author-notes><corresp id="cor1"><bold>Correspondence:</bold> Dr. Dahiya Ritu, Department of Periodontology and Implantology, P.D.M. Dental College, Bahadurgarh, Haryana, India. E-mail: <email xlink:href="ritu.raist@gmail.com">ritu.raist@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2013</year></pub-date><volume>4</volume><issue>1</issue><fpage>48</fpage><lpage>53</lpage><permissions><copyright-statement>Copyright: &#x000a9; Contemporary Clinical Dentistry</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective:</title><p>The aim of this study was to evaluate and compare the efficacy of subgingivally delivered Minocycline microspheres and 25% Metronidazole gel when used as an adjunct to scaling and root planing (SRP) in the treatment of chronic periodontitis.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>A randomized, controlled, single center study was conducted involving 60 sites in 20 patients suffering from moderate to advanced chronic periodontitis. Each patient contributed three sites which were randomized to three treatment groups: SRP + insertion of Minocycline microspheres at day 1 (Group A), SRP + insertion of Metronidazole gel at day 1 and at day 7 (Group B), and SRP alone (Group C). Gingival index (GI), plaque index (PI), probing pocket depth (PPD), and clinical attachment level (CAL) were recorded at day 1, 1 month, and 3 months post therapy.</p></sec><sec id="st3"><title>Results:</title><p>All treatments showed significant reductions in PPD and CAL at 1 and 3 months when compared to baseline values (<italic>P</italic> &#x0003c; 0.001). At 3 months, sites treated with minocycline showed an additional reduction in PPD of 0.85 &#x000b1; 0.03 mm, significantly greater than SRP alone. Differences in mean PPD reduction between Group B and Group C and between Group A and Group B were not significant. At 3 months, difference in CAL gain between Group A and C was 0.50 &#x000b1; 0.45, which was statistically significant and between Group B and C was 0.35 &#x000b1; 0.11, which was not found to be statistically significant (<italic>P</italic> = 0.20). Differences in relative CAL between Group A and Group B were also not found to be statistically significant (<italic>P</italic> = 0.53).</p></sec><sec id="st4"><title>Conclusion:</title><p>The results concluded that treatment with Minocycline microspheres and Metronidazole gel improve PPD and CAL in patients with periodontitis compared to SRP alone.</p></sec></abstract><kwd-group><kwd>Local drug delivery</kwd><kwd>metronidazole gel</kwd><kwd>minocycline microspheres</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>The traditional treatment modality of scaling and root planing remains the &#x02018;gold standard&#x02019; for the non-surgical management of chronic periodontitis.[<xref rid="ref1" ref-type="bibr">1</xref>] Mechanical therapy may, however, fail to reduce or eliminate the anaerobic infection at the base of the pocket, within the gingival tissue or in furcations. Some of the periodontal pathogens travel into lacunar defects in the cementum, which further extend into radicular dentin. These can act as bacterial reservoirs from which re-colonization of mechanically treated root surfaces can occur. The bacterial reservoirs not eliminated by conventional periodontal therapy can be further suppressed with the use of chemotherapeutic agents.[<xref rid="ref2" ref-type="bibr">2</xref>]</p><p>Localized antimicrobial therapy, in particular, has evoked growing interest because of the site-specific nature of periodontal infections, the higher concentration of anti-microbial agent subgingivally and reduced side-effects of systemic antibiotic use.[<xref rid="ref3" ref-type="bibr">3</xref>] Various locally delivered chemotherapeutic agents available are: Tetracycline fibers, metronidazole gel, minocycline ointment and minocycline microspheres, chlorhexidine chip, doxycycline hyclate, etc.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p><italic>In vitro</italic> studies have shown minocycline hydrochloride to be one of the most active anti-biotic against most microorganisms associated with periodontal disease. Moreover out of all the tetracyclines, minocycline has the most marked substantivity and greater lipid solubility.[<xref rid="ref5" ref-type="bibr">5</xref>] Recently, minocycline has been incorporated into a controlled release bioresorbable polymer, which serves as the encapsulating medium (Arestin&#x02122; Ora Pharma, Inc).</p><p>Among the various locally delivered chemotherapeutic agents metronidazole, a member of nitroimidazole class of antibiotics has bactericidal action against anaerobes, such as <italic>Prevotela intermedia</italic>, <italic>Porphyromonas gingivalis</italic>, <italic>Tannerella forsythia</italic>, Fusobacterium species and spirochetes like <italic>Treponema denticola</italic>, <italic>Treponema vincentii</italic>, which are generally believed to be the main pathogens associated with periodontitis.[<xref rid="ref6" ref-type="bibr">6</xref>] A metronidazole-containing gel (25%) (Elyzol<sup>&#x000ae;</sup>, Alpharma ApS, Denmark) is available for use as local drug-delivery agent.</p><p>Many clinical studies have been conducted to assess the efficacy of local drug delivery systems as adjuncts to SRP or as the sole treatment for untreated periodontal lesions.[<xref rid="ref7" ref-type="bibr">7</xref><xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] Few studies have assessed the comparative efficacy of a number of currently marketed systems.[<xref rid="ref10" ref-type="bibr">10</xref>]</p><p>The aim of the present study was to evaluate and compare the efficacy of two local delivery products, one containing minocycline microspheres, Arestin (Ora Pharma Inc., USA) and other containing metronidazole gel, Elyzol (Alpharma ApS, Denmark) used as an adjunct to SRP in the treatment of chronic periodontitis.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>The subjects for this randomized controlled, split mouth study were selected from the out-patient department of Periodontics, D.A.V. (C) Dental College and Hospital, Yamuna Nagar (Haryana), India. Approval of the study was obtained from the institutional review board of Health Sciences University, Rohtak, Haryana, India to which D.A.V (C) Dental College and Hospital, Yamuna Nagar is affiliated.</p><p>In this clinical trial 20 patients (9 females, 11 males) were enrolled in the study. A total of 60 sites among the enrolled subjects were selected for the study. Each patient had at least three teeth with probing pocket depth of 5-8 mm that bled on probing at the initial visit. The selected patients should not have received local and/or systemic antibiotic therapy within the last 6 months prior to the baseline examination of the study. Before starting the trial all the patients underwent full mouth supra and subgingival SRP using an ultrasonic scaler and curettes. They were given careful instructions for self-performed oral hygiene measures. The study was explained to patients and all patients signed informed consent at enrolment. The selected qualifying sites were randomly divided into any of the three parallel treatment arms according to split mouth design. (1) Group A (20 sites): Treated with SRP followed by placement of minocycline microspheres. (2) Group B (20 sites): Treated with SRP followed by placement of metronidazole gel at baseline and again at 7 days. (3) Group C (Control group) (20 sites): Treated with SRP alone.</p><p>Subgingival administration of minocycline microspheres was accomplished by inserting the unit-dose cartridge to the base of the periodontal pocket and then pressing the thumb and index finger by the handle mechanism to expel the powder to the base of the pocket [<xref ref-type="fig" rid="F1">Figure 1</xref>]. The metronidazole gel was supplied with a flexible, blunt needle [<xref ref-type="fig" rid="F2">Figure 2</xref>]. This facilitates the application of the gel without traumatizing or damaging the periodontal tissues. After isolating and drying the sites, metronidazole gel was injected into the periodontal pocket and no periodontal dressing was used.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Insertion of minocycline microspheres</p></caption><graphic xlink:href="CCD-4-48-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Insertion of metronidazole gel</p></caption><graphic xlink:href="CCD-4-48-g002"/></fig><p>Four clinical variables including plaque index,[<xref rid="ref11" ref-type="bibr">11</xref>] gingival index,[<xref rid="ref11" ref-type="bibr">11</xref>] probing pocket depth,[<xref rid="ref12" ref-type="bibr">12</xref>] and clinical attachment level[<xref rid="ref13" ref-type="bibr">13</xref>] were evaluated at the baseline prior to insertion of test agents and at 1 and 3 months interval.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>Computer software (SPSS 10.0 for windows) was used for data analysis. Mean values and standard deviations were calculated for plaque index, gingival index, probing pocket depth and clinical attachment level for all the three groups and at different time intervals. Paired &#x02018;<italic>t</italic>-test&#x02019; was used for comparisons with in the groups and student &#x0201c;<italic>t</italic>-test&#x0201d; was used for intergroup comparisons. Results were regarded as statistically significant when <italic>P</italic> &#x0003c; 0.05.</p><sec id="sec2-1"><title>Plaque index and gingival index</title><p>The mean plaque index for all three treatment groups at baseline was2.46 &#x000b1; 0.54 whereas the mean value at 1 and 3 months were 1.06 &#x000b1; 0.29 and 0.71 &#x000b1; 0.25 respectively. There was significant reduction in plaque index scores at both 1 month and 3 months interval [<xref ref-type="table" rid="T1">Table 1</xref>]. The mean gingival index at baseline was 1.92 &#x000b1; 0.55, whereas the mean value at 1 and 3 months was 0.98 &#x000b1; 0.30 and 0.73 &#x000b1; 0.19, respectively. There was significant reduction in plaque index scores at both 1 month and 3 months interval [<xref ref-type="table" rid="T2">Table 2</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Comparison of mean values of plaque index scores at Baseline, 1 month and 3 months</p></caption><graphic xlink:href="CCD-4-48-g003"/></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Comparison of mean values of gingival index scores at baseline, 1 month and 3 months</p></caption><graphic xlink:href="CCD-4-48-g004"/></table-wrap></sec><sec id="sec2-2"><title>Probing pocket depth</title><p>In the present study, intragroup observations showed statistically significant reduction in pocket depth from baseline to 1 month and 3 months in all 3 groups [<xref ref-type="table" rid="T3">Table 3</xref>]. At the termination of the study (at 3 months), Group A showed an additional pocket depth reduction of 0.85 &#x000b1; 0.03 over Group C, which was statistically significant and Group B showed an additional reduction of 0.50 &#x000b1; 0.09 over Group C, which was statistically non-significant. Difference in mean pocket depth reduction between Group A and B was also non-significant (0.35 &#x000b1; 0.12). <xref ref-type="fig" rid="F3">Figure 3</xref> represents mean pocket depth reduction at different time intervals.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Intergroup comparison of mean values of pocket depth at baseline, 1 month and 3 months</p></caption><graphic xlink:href="CCD-4-48-g005"/></table-wrap><fig id="F3" position="float"><label>Figure 3</label><caption><p>Mean pocket depth reduction at different time intervals</p></caption><graphic xlink:href="CCD-4-48-g006"/></fig></sec><sec id="sec2-3"><title>Clinical attachment level</title><p>Relative gain in clinical attachment levels (CAL) were observed in all sites when compared with baseline values. The improvements were statistically significant for all the three groups at 1 and 3 months when compared to baseline [<xref ref-type="table" rid="T4">Table 4</xref>]. At the termination of study, Group A showed 0.50 &#x000b1; 0.45 mm more improvement in clinical attachment level than Group C, which was statistically significant. Whereas, Group B produced 0.25 &#x000b1; 0.11 mm more improvement in clinical attachment level than Group C which was statistically non-significant when compared to Group C at 3 months. The difference in CAL gain between Group A and B at 3 months was 0.15 &#x000b1; 0.56 which was statistically non-significant. <xref ref-type="fig" rid="F4">Figure 4</xref> shows mean clinical attachment gain at different time intervals.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Intergroup comparison of mean values of clinical attachment level at baseline, 1 month and 3 months</p></caption><graphic xlink:href="CCD-4-48-g007"/></table-wrap><fig id="F4" position="float"><label>Figure 4</label><caption><p>Mean clinical attachment gain at different time intervals</p></caption><graphic xlink:href="CCD-4-48-g008"/></fig></sec><sec id="sec2-4"><title>Adverse reaction</title><p>Adverse effects were in direct relation to the treatments (scaling, application of microspheres or gel). The most common complaint was related to the bitter taste of the metronidazole reported in majority of patients. The other minor complaints included tooth sensitivity, dental pain, headache, etc., which did not influence patient compliance.</p><p>No clinically significant changes in vital signs or hard- or soft-tissues were noted during the course of study.</p></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The present study was designed to evaluate the clinical efficacy of locally delivered minocycline microspheres and metronidazole gel use as an adjunct to SRP.</p><p>The use of local drugs dates back to 1979 when Goodson <italic>et al</italic>., 1<sup>st</sup> discovered local drug delivery system for tetracycline antibiotic.[<xref rid="ref14" ref-type="bibr">14</xref>] Since then, chlorhexidine (Addy 1982),[<xref rid="ref15" ref-type="bibr">15</xref>] doxycycline (Garret 1999),[<xref rid="ref8" ref-type="bibr">8</xref>] minocycline (Jones 1994),[<xref rid="ref5" ref-type="bibr">5</xref>] metronidazole (Addy 1982)[<xref rid="ref15" ref-type="bibr">15</xref>] and ofloxacin (Higashi 1990)[<xref rid="ref16" ref-type="bibr">16</xref>] antimicrobials in the formulation of local delivery devices, have been used for the treatment of periodontitis with variable results.</p><p>Amongst the advantages of local drug delivery, most important is that it can attain 100-fold higher concentration of an anti-microbial agent in subgingival sites compared with a systemic drug regimen. It may employ antimicrobial agents not suitable for systemic administration, e.g., broad-spectrum antiseptic solutions. It reduces potential problems with patient compliance. It reduces systemic side effects. It reduces the risk of developing drug-resistant microbial populations at non oral body sites.[<xref rid="ref17" ref-type="bibr">17</xref>]</p><p>Tetracycline group of antibiotics are the most commonly used active agents for the treatment of periodontitis because they are active against periodontopathic micro-organisms, and they offer better resorption, protein binding, diffusion into tissue structure and anti-collagenase property. High degree substantivity is one of the most important characteristics of the drugs and agents to be used for control of microbial plaque.[<xref rid="ref18" ref-type="bibr">18</xref>] Substantive effects of the tetracyclines within the periodontal pocket-adjacent tooth surface environment have been well documented.[<xref rid="ref19" ref-type="bibr">19</xref>] The local drug delivery system (Arestin&#x02122;) in the present study uses a technology of microencapsulating minocycline hydrochloride in a bioabsorbable polymer as the vehicle (polyglycolide-co-dl-lactide). The resulting microspheres are administered in powder form into the diseased periodontal site. Immediately upon contact with moisture, the polymer begins to hydrolyze and release minocycline. The administration results in a sustained local release of the antibiotic whereby concentrations of 340 &#x003bc;gm/ml have been measured in human crevicular fluid even after 14 days. These concentrations far exceed the Minimum Inhibitory Concentrations (MICs) for periodontal pathogens.[<xref rid="ref20" ref-type="bibr">20</xref>]</p><p>Metronidazole specifically targets anaerobic microorganisms but has essentially no activity against aerobic or microaerophilic bacteria. Since anaerobic bacteria are believed to be the predominant causative factor in periodontitis, it might be advantageous to use it in the treatment of chronic periodontitis.[<xref rid="ref21" ref-type="bibr">21</xref>]</p><p>The local drug delivery system (Elyzol) uses a semi-solid suspension of metronidazole benzoate in a mixture of glyceryl mono-oleate and triglyceride (Sesame oil). It is applied in viscous consistency to the pocket where it is liquidized by the body heat and then hardens again forming crystals in contact with water. As a precursor, the preparation contains metronidazole-benozate, which is converted into active substances by esterases in the Gingival Crevicular Fluid (GCF). The MIC<sub>50</sub> (minimum inhibiting concentration with 50% inhibitory effect) for the suspected pathogens has been shown to be maintained throughout a 24-hour period after one single gel application.[<xref rid="ref22" ref-type="bibr">22</xref>] Since metronidazole does not have substantivity beyond 24 h, the application of Elyzol was repeated at 7 days, to maintain effective levels for periopathogens, and to produce additional benefit of the drug for remaining microbes.[<xref rid="ref23" ref-type="bibr">23</xref>]</p><p>It is well established that in organized biofilms, the microorganisms are less susceptible to antimicrobials and there is retarded or incomplete penetration of the agent into the biofilm.[<xref rid="ref24" ref-type="bibr">24</xref>] Thus, previous biofilm removal could favor greater effectiveness of the antibiotic against subgingival pathogens, leading to improved healing response.[<xref rid="ref25" ref-type="bibr">25</xref>]</p><p>A split mouth design was used in the present study. It has been suggested that a split mouth design may induce a carry-over effect of subgingival antibiotic administration due to wash out of anti-microbial agent and boosting of systemic responses.[<xref rid="ref10" ref-type="bibr">10</xref>] Although, its&#x02019; true, Imery 1986 believed that gingival crevicular fluid is relatively isolated from saliva.[<xref rid="ref26" ref-type="bibr">26</xref>] Moreover, split mouth design has the big advantage in that it allows paired comparisons to be made.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>All the patients showed statistically and clinically significant improvements in gingival and plaque index at both follow-up visit, when compared to baseline levels. Both the gingival and plaque indices remained satisfactory during the entire study period, suggesting that patients complied with the oral hygiene instructions.[<xref rid="ref13" ref-type="bibr">13</xref>]</p><p>In the group treated with minocycline microspheres (Group A), the clinical reduction in probing depth and gain in CAL was substantial and consistent with the reduction of inflammation in the adjacent gingival tissues and reduction in subgingival bacterial load due to minocycline.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref28" ref-type="bibr">28</xref>] The seemingly greater closure of pockets could be due to possibility of minocycline absorbing onto mineralized dental structures, where it may act as a transient reservoir of the antimicrobial agent during period of substantivity. The drug release kinetics of minocycline is of zero order i.e., it maintains a steady drug concentration for prolonged period of time.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p>In the group treated with metronidazole gel (Group B) the clinical reduction in probing depth was substantial and consistent with the reduction of inflammation in the adjacent gingival tissues and reduction in subgingival bacterial load due to metronidazole. This reduction in inflammation and presence of healing in the connective tissue subjacent to the junctional epithelium is the primary reason for reducing the depth of periodontal probe penetration after treatment.[<xref rid="ref23" ref-type="bibr">23</xref>] Metronidazole follows first order kinetics i.e., gel provides increased drug concentration for 24 h after which it subsequently decreases rapidly at a rate directly proportional to their pocket concentration.[<xref rid="ref27" ref-type="bibr">27</xref>]</p><p>Clinical improvement, that is reduction in pocket probing depth and gain in clinical attachment in Group C is due to elimination of local etiologic factors, It has also been proposed that SRP may also elicit a local and systemic host response that would aid in eliminating local infection and promote healing.[<xref rid="ref29" ref-type="bibr">29</xref>]</p><p>The greater gain in CAL in Group A than Group B could be attributed to the non-antibiotic properties of Tetracyclines namely anti-collagenase and anti-inflammatory effect.</p><p>Paquette <italic>et al</italic>.(2004)[<xref rid="ref30" ref-type="bibr">30</xref>] and Williams <italic>et al</italic>.(2001)[<xref rid="ref20" ref-type="bibr">20</xref>] concluded that minocycline microspheres were more effective than SRP alone in reducing probing depths in chronic Periodontitis patients. Griffiths <italic>et al</italic>.(2000)[<xref rid="ref26" ref-type="bibr">26</xref>] concluded that metronidazole gel produced significantly better results in terms of pocket depth and CAL when used in combination with SRP. These reports demonstrated improvements related to probing depth reductions and gain in clinical attachment levels that coincided with the results of the current study.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>All treatment groups showed significant reduction in probing pocket depth and clinical attachment level gain at 1 and 3 months when compared to baseline. Minocycline treated group showed better efficacy in terms of gain in clinical attachment level and reduction in probing pocket depth followed by metronidazole treated group and then by SRP group.</p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandekerckhove</surname><given-names>BN</given-names></name><name><surname>Quirynen</surname><given-names>M</given-names></name><name><surname>van Steenberghe</surname><given-names>D</given-names></name></person-group><article-title>The use of locally delivered minocycline in the treatment of chronic periodontitis. A review of the literature</article-title><source>J Clin Periodontol</source><year>1998</year><volume>25</volume><fpage>964</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9839854</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adriaens</surname><given-names>PA</given-names></name><name><surname>De Boever</surname><given-names>JA</given-names></name><name><surname>Loesche</surname><given-names>WJ</given-names></name></person-group><article-title>Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. A reservoir of periodontopathic bacteria</article-title><source>J Periodontol</source><year>1988</year><volume>59</volume><fpage>222</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">3164373</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tonetti</surname><given-names>MS</given-names></name><name><surname>Pini-Prato</surname><given-names>G</given-names></name><name><surname>Cortellini</surname><given-names>P</given-names></name></person-group><article-title>Principles and clinical applications of periodontal controlled drug delivery with tetracycline fibers</article-title><source>Int J Periodontics Restorative Dent</source><year>1994</year><volume>14</volume><fpage>421</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">7751109</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenstein</surname><given-names>G</given-names></name><name><surname>Polson</surname><given-names>A</given-names></name></person-group><article-title>The role of local drug delivery in the management of periodontal diseases: A comprehensive review</article-title><source>J Periodontol</source><year>1998</year><volume>69</volume><fpage>507</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9623893</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>AA</given-names></name><name><surname>Kornman</surname><given-names>KS</given-names></name><name><surname>Newbold</surname><given-names>DA</given-names></name><name><surname>Manwell</surname><given-names>MA</given-names></name></person-group><article-title>Clinical and microbiological effects of controlled-release locally delivered minocycline in periodontitis</article-title><source>J Periodontol</source><year>1994</year><volume>65</volume><fpage>1058</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">7853130</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awartani</surname><given-names>FA</given-names></name><name><surname>Zulqarnain</surname><given-names>BJ</given-names></name></person-group><article-title>Comparison of the clinical effects of subgingival application of metronidazole 25% gel and scaling in the treatment of adult periodontitis</article-title><source>Quintessence Int</source><year>1998</year><volume>29</volume><fpage>41</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9611474</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortelli</surname><given-names>JR</given-names></name><name><surname>Querido</surname><given-names>SM</given-names></name><name><surname>Aquino</surname><given-names>DR</given-names></name><name><surname>Ricardo</surname><given-names>LH</given-names></name><name><surname>Pallos</surname><given-names>D</given-names></name></person-group><article-title>Longitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitis</article-title><source>J Periodontol</source><year>2006</year><volume>77</volume><fpage>161</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16460239</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Drisko</surname><given-names>CH</given-names></name><name><surname>Adams</surname><given-names>DF</given-names></name><name><surname>Bandt</surname><given-names>C</given-names></name><name><surname>Beiswanger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis</article-title><source>J Periodontol</source><year>1999</year><volume>70</volume><fpage>490</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">10368053</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kn&#x000f6;fler</surname><given-names>G</given-names></name><name><surname>Purschwitz</surname><given-names>R</given-names></name><name><surname>Jentsch</surname><given-names>H</given-names></name><name><surname>Birkenmeier</surname><given-names>G</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name></person-group><article-title>Gingival crevicular fluid levels of aspartate aminotransferase and alpha2-macroglobulin before and after topical application of metronidazole or scaling and root planing</article-title><source>Quintessence Int</source><year>2008</year><volume>39</volume><fpage>381</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19088952</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radvar</surname><given-names>M</given-names></name><name><surname>Pourtaghi</surname><given-names>N</given-names></name><name><surname>Kinane</surname><given-names>DF</given-names></name></person-group><article-title>Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets</article-title><source>J Periodontol</source><year>1996</year><volume>67</volume><fpage>860</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8884642</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmerman</surname><given-names>MF</given-names></name><name><surname>van der Weijden</surname><given-names>GA</given-names></name><name><surname>van Steenbergen</surname><given-names>TJ</given-names></name><name><surname>Mantel</surname><given-names>MS</given-names></name><name><surname>de Graaff</surname><given-names>J</given-names></name><name><surname>van der Velden</surname><given-names>U</given-names></name></person-group><article-title>Evaluation of the long-term efficacy and safety of locally-applied minocycline in adult periodontitis patients</article-title><source>J Clin Periodontol</source><year>1996</year><volume>23</volume><fpage>707</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">8877655</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>HK</given-names></name><name><surname>Chei</surname><given-names>CJ</given-names></name></person-group><article-title>Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis</article-title><source>J Periodontal Res</source><year>2005</year><volume>40</volume><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15613075</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Steenberghe</surname><given-names>D</given-names></name><name><surname>Bercy</surname><given-names>P</given-names></name><name><surname>Kohl</surname><given-names>J</given-names></name><name><surname>De Boever</surname><given-names>J</given-names></name><name><surname>Adriaens</surname><given-names>P</given-names></name><name><surname>Vanderfaeillie</surname><given-names>A</given-names></name><etal/></person-group><article-title>Subgingival minocycline hydrochloride ointment in moderate to severe chronic adult periodontitis: A randomized, double-blind, vehicle-controlled, multicenter study</article-title><source>J Periodontol</source><year>1993</year><volume>64</volume><fpage>637</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8396177</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodson</surname><given-names>JM</given-names></name><name><surname>Haffajee</surname><given-names>A</given-names></name><name><surname>Socransky</surname><given-names>SS</given-names></name></person-group><article-title>Periodontal therapy by local delivery of tetracycline</article-title><source>J Clin Periodontol</source><year>1979</year><volume>6</volume><fpage>83</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">379050</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addy</surname><given-names>M</given-names></name><name><surname>Langeroudi</surname><given-names>M</given-names></name></person-group><article-title>Comparison of the immediate effects on the sub-gingival microflora of acrylic strips containing 40% chlorhexidine, metronidazole or tetracycline</article-title><source>J Clin Periodontol</source><year>1984</year><volume>11</volume><fpage>379</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">6589239</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>K</given-names></name><name><surname>Morisaki</surname><given-names>K</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Kitamura</surname><given-names>M</given-names></name><name><surname>Fujimoto</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>S</given-names></name><etal/></person-group><article-title>Local ofloxacin delivery using a controlled-release insert (PT-01) in the human periodontal pocket</article-title><source>J Periodontal Res</source><year>1990</year><volume>25</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2137167</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rams</surname><given-names>TE</given-names></name><name><surname>Slots</surname><given-names>J</given-names></name></person-group><article-title>Local delivery of antimicrobial agents in the periodontal pocket</article-title><source>Periodontol 2000</source><year>1996</year><volume>10</volume><fpage>139</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">9567941</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodson</surname><given-names>JM</given-names></name></person-group><article-title>Pharmcokinetic principles controlling the efficacy of local therapy</article-title><source>J Dent Res</source><year>1989</year><volume>68</volume><fpage>1625</fpage><lpage>32</lpage></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polson</surname><given-names>AM</given-names></name><name><surname>Garrett</surname><given-names>S</given-names></name><name><surname>Stoller</surname><given-names>NH</given-names></name><name><surname>Bandt</surname><given-names>CL</given-names></name><name><surname>Hanes</surname><given-names>PJ</given-names></name><name><surname>Killoy</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results</article-title><source>J Periodontol</source><year>1997</year><volume>68</volume><fpage>119</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">9058328</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>RC</given-names></name><name><surname>Paquette</surname><given-names>DW</given-names></name><name><surname>Offenbacher</surname><given-names>S</given-names></name><name><surname>Adams</surname><given-names>DF</given-names></name><name><surname>Armitage</surname><given-names>GC</given-names></name><name><surname>Bray</surname><given-names>K</given-names></name><etal/></person-group><article-title>Treatment of periodontitis by local administration of minocycline microspheres: A controlled trial</article-title><source>J Periodontol</source><year>2001</year><volume>72</volume><fpage>1535</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">11759865</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ainamo</surname><given-names>J</given-names></name><name><surname>Lie</surname><given-names>T</given-names></name><name><surname>Ellingsen</surname><given-names>BH</given-names></name><name><surname>Hansen</surname><given-names>BF</given-names></name><name><surname>Johansson</surname><given-names>LA</given-names></name><name><surname>Karring</surname><given-names>T</given-names></name><etal/></person-group><article-title>Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis</article-title><source>J Clin Periodontol</source><year>1992</year><volume>19</volume><fpage>723</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1447392</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoltze</surname><given-names>K</given-names></name></person-group><article-title>Concentration of metronidazole in periodontal pockets after application of a metronidazole 25% dental gel</article-title><source>J Clin Periodontol</source><year>1992</year><volume>19</volume><fpage>698</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">1447389</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzel</surname><given-names>M</given-names></name><name><surname>Flor&#x000e8;s-de-Jacoby</surname><given-names>L</given-names></name></person-group><article-title>Topical metronidazole application compared with subgingival scaling. A clinical and microbiological study on recall patients</article-title><source>J Clin Periodontol</source><year>1996</year><volume>23</volume><fpage>24</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8636453</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheie</surname><given-names>AA</given-names></name><name><surname>Petersen</surname><given-names>FC</given-names></name></person-group><article-title>The biofilm concept: Consequences for future prophylaxis of oral diseases?</article-title><source>Crit Rev Oral Biol Med</source><year>2004</year><volume>15</volume><fpage>4</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">14761896</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>CB</given-names></name><name><surname>Karpinia</surname><given-names>K</given-names></name><name><surname>Baehni</surname><given-names>P</given-names></name></person-group><article-title>Chemotherapeutics: Antibiotics and other antimicrobials</article-title><source>Periodontol 2000</source><year>2004</year><volume>36</volume><fpage>146</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">15330947</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>GS</given-names></name><name><surname>Smart</surname><given-names>GJ</given-names></name><name><surname>Bulman</surname><given-names>JS</given-names></name><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Shrowder</surname><given-names>J</given-names></name><name><surname>Newman</surname><given-names>HN</given-names></name></person-group><article-title>Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel</article-title><source>J Clin Periodontol</source><year>2000</year><volume>27</volume><fpage>910</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11140558</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klinge</surname><given-names>B</given-names></name><name><surname>Attstr&#x000f6;m</surname><given-names>R</given-names></name><name><surname>Karring</surname><given-names>T</given-names></name><name><surname>Kisch</surname><given-names>J</given-names></name><name><surname>Lewin</surname><given-names>B</given-names></name><name><surname>Stoltze</surname><given-names>K</given-names></name></person-group><article-title>3 regimens of topical metronidazole compared with subgingival scaling on periodontal pathology in adults</article-title><source>J Clin Periodontol</source><year>1992</year><volume>19</volume><fpage>708</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">1447391</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>LR</given-names></name><name><surname>Stoller</surname><given-names>NH</given-names></name><name><surname>Polson</surname><given-names>A</given-names></name><name><surname>Harrold</surname><given-names>CQ</given-names></name><name><surname>Ryder</surname><given-names>M</given-names></name><name><surname>Garrett</surname><given-names>S</given-names></name></person-group><article-title>The effects of subgingival calculus on the clinical outcomes of locally-delivered controlled-release doxycycline compared to scaling and root planing</article-title><source>J Clin Periodontol</source><year>2002</year><volume>29</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">11895536</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Offenbacher</surname><given-names>S</given-names></name></person-group><article-title>Periodontal diseases: Pathogenesis</article-title><source>Ann Periodontol</source><year>1996</year><volume>1</volume><fpage>821</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">9118282</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paquette</surname><given-names>DW</given-names></name><name><surname>Hanlon</surname><given-names>A</given-names></name><name><surname>Lessem</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>RC</given-names></name></person-group><article-title>Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: Secondary analysis of a phase 3 trial</article-title><source>J Periodontol</source><year>2004</year><volume>75</volume><fpage>531</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">15152816</pub-id></element-citation></ref></ref-list></back></article>